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It is widely accepted that increasing levels of obesity places considerable stress not only on the overweight/obese individuals, but also on public health expenditures. Nutritional and physical activity interventions provide the potential to mitigate some of the negative consequences of poor lifestyle habits.
Monitoring changes only in body mass fails to provide the more detailed feedback on body composition that is often recommended (Thomson, Brinkworth, Buckley, Noakes, & Clifton, 2007) . Advanced measurement of body composition using dual-energy X-ray absorptiometry (DXA) provides detailed analyses that are considered both valid and reliable, to the extent of being a reference method for body composition comparison (Anderson, Erceg, & Schroeder, 2012; Bosy-Westphal et al., 2008) . However, DXA has several limitations, including: it is not routinely accessible since it requires a substantial capital outlay; it requires trained operators; it is not portable for field assessments; and it exposes participants to a very mild dose of ionizing radiation.
Hence, use of such equipment is counter to the behavioural intervention theories which often suggest methods to facilitate motivation and enhance compliance that include self-monitoring strategies (Michie, Johnston, Francis, Hardeman, & Eccles, 2008) . For adequately powered field studies, the use of relatively inexpensive, simple and accurate methods that can be used to monitor changes in body composition, especially fat and lean mass, and using a real-world scenario rather than a highly-controlled laboratory setting, would be more appropriate.
Consumer-based bioelectric impedance analysis (BIA) devices have become increasingly popular for self-monitoring of body composition as they are often affordable, portable, safe, and require no training ( Kyle, Bosaeus, De Lorenzo, Deurenberg, Elia, Manuel Gomez, et al., 2004) . Although studies often report extremely high levels of reliability for a range of BIA devices (Macfarlane, 2007) , there is less agreement on their criterion validity. When compared to DXA, some crosssectional studies using healthy adults have shown acceptable levels of validity using single-frequency (Demura, Sato, & Kitabayashi, 2004) , and multifrequency devices (Anderson et al., 2012; Sun et al., 2005) , yet others report less favourable comparisons (Andreoli et al., 2002) .
Although BIA devices may show significant bias compared to DXA in crosssectional studies, it is important to be able to find widely available methods that A relatively small number of similar studies have examined whether single and/or multi-frequency BIA devices can accurately monitor changes in body composition during weight loss programmes, although most focus on overweight/obese or clinical patients (Jebb et al., 2007; Li et al., 2013; Miyatani, Yang, Thomas, Craven, & Oh, 2012; Pietiläinen et al., 2013; Thomson et al., 2007; Verdich et al., 2011) . These studies report inconsistent findings; most reported Whilst BIA is routinely used to estimate fat mass, it also has the advantage of being the only widely available and simple electronic predictive method that estimates lean mass (Böhm & Heitmann, 2013; Wells & Fewtrell, 2006) , and indeed can estimate muscle mass accurately compared with DXA (Bosaeus, Wilcox, Rothenberg, & Strauss, 2013) . More recently, BIA has also been used to develop predictive equations to estimate bone mineral content (Patil, Patkar, Mandlik, Kuswarkar, & Jindal, 2012 ). Yet to our best knowledge, no field study to date has examined the ability of recently-developed portable dual frequency BIA to monitor changes in fat mass, lean mass and bone mass over a training programme in a mixed group of predominantly normal-weight healthy adults.
Based on studies cited earlier, it was hypothesized that compared to the reference DXA, the Tanita BIA would adequately monitor qualitative changes (a gain or loss) in fat mass and lean mass only, but be less sensitive in monitoring quantitative changes in body composition at the individual level.
Methods
Participants: A sample of 136 adults aged 18-66 years volunteered (42 males, 94 females; mean age 44yr, SD = 12), with their baseline anthropometric characteristics shown in Table 1 . The participants were all recruited through the "Exercise for Life" program within the Active Health Clinic at the University of Hong Kong, and were predominantly university staff members or family members. All participants completed a health history questionnaire, the PAR-Q, Protocol: The Exercise for Life program was designed to be a 10-week "realworld" lifestyle/fitness intervention aimed at enhancing metabolic health, with expected reductions in fat mass and improvements in lean mass. An exercise program was individually tailored for each participant and monitored by a qualified exercise specialist. Each person participated in a supervised exercise class 3 days per week, beginning with a range of health-related measurements at baseline that included stature (to nearest mm, Seca stadiometer), mass (to nearest 0.1kg, Tanita BC545N), and body composition using both BIA and DXA.
These measurements were repeated at the end of the intervention period using the same standardized procedures.
Bioelectrical Impedance Analysis (BIA): The BIA machine was the portable Tanita Innerscan BC545N (Tanita Corp, Tokyo). This uses 10 electrodes (3 under each foot, and two in each hand using a retractable handle), with a dualfrequency analysis at 6.25kHz and 50kHz (Knechtle et al., 2010) , to provide estimates of total (and segmental) lean mass, fat mass and bone mass.
Participants were asked to refrain from vigorous physical activity, or consuming food, alcohol or diuretic fluids for 4 hours beforehand, to be normally hydrated and were invited to void the bladder and bowels immediately prior to measurement. Each participant wore minimal clothing, had their gender, age and stature entered into the device, then stood on the device with bare feet and grasped the retractable handle according to the manufacturer's 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 DXA: A full body DXA scanner (Explorer S/N 91075, Hologic Inc., Waltham, USA) was used to measure body composition and to report total lean mass, fat mass and bone mass. For the purpose of this study, DXA was considered the reference measure. Trained and ISCD-certified DXA technicians performed all DXA scans according to the manufacturer's guidelines in operating the machine, positioning the participants and to analysing the results. For the facility used in this study, typical coefficients of variation for each body compartment from duplicate analyses are 0.4% for lean mass, 1.4% for fat mass, and 1.0% for bone mass.
Statistical Analysis: The variables of lean mass, fat mass, and bone mass were compared for both the BIA and the DXA using a within-method analysis (pre v post), and also a between-method analysis (BIA v DXA) via paired T-tests with statistical significance determined when p<0.05, as well as Bland-Altman analyses (Bland & Altman, 1986) . Percentage changes after intervention, their limits of agreement (LOA), along with Cohen effect sizes (d) were also calculated with small, medium and large effects defined as around 0.2, 0.5 and 0.8 respectively (Cohen, 1988) . Analyses were conducted using MedCalc statistical software (MedCalc Software, Ostend, Belgium). Table 2 over the 10 weeks of the lifestyle intervention the participants on average reduced their total body mass by 313 g (-0.5%), which was statistically significant (t = 2.43, p = 0.008), although a small effect size (0.20). The 0.802kg reduction in fat mass measured by the DXA was significant (t = 8.53, p<0.001), and a -3.7% loss of fat mass, which was statistically larger (t = 3.072, p = 0.003) than the significant 0.486kg reduction in fat mass measured by the Tanita BIA (t = 3.68, p<0.001), with effect size changes being small (<0.20).
< Table 1 near here >

Results
As shown in
The reduction in fat mass measured by the BIA represented just over half (60.5%) of the fat loss measured by the reference DXA, and represented a substantial effect size difference of 0.72. The difference between the fat loss assessed by BIA and DXA is also shown in the Bland-Altman graph (Fig 1) , which depicts a systematic error (with a mean bias of 0.32kg; LoA -2.39 -3.03) that is proportional to the size of the measured value, with the random errors relatively uniform. The mean bias of 0.32kg shows the BIA typically underestimated the fat mass loss. In terms of the qualitative/directional agreement, BIA only agreed 70% of the time with the directional (gain v loss of fat) when compared to DXA.
< Table 2 near here > Over the intervention the DXA monitored a statistically significant mean gain of 0.477kg of lean mass (t = -5.77, p<0.001), representing a 0.3% gain in lean mass, which was not statistically different (t = 0.86, p=0.392) compared to the nonsignificant mean gain of 0.084kg measured by BIA; effect size changes in lean mass were both trivial (<0.1). The increase in lean mass measured by the BIA represented only 17.6% of the lean mass gain measured by the reference DXA, with the effect size difference being substantial (0.79). The Bland-Altman graph 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Table 2 also shows significant, but moderate, Spearman correlations were seen in absolute mass changes between DXA and BIA of 0.511 (fat), 0.362 (lean), whilst the correlation for bone of 0.172 was weak, but remained just statistically significant (p=0.047).
Discussion
It is very helpful for not only health professionals but also motivated members of the community to be able to objectively assess aspects of body composition using relatively inexpensive and widely available consumer products. The ability of BIA devices to accurately monitor changes in body composition are of primary 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 importance in many studies rather than their cross-sectional validity (Jebb et al., 2007) . This "real-world" study presents novel data to show that when compared to the reference device (DXA), a commonly available consumer BIA device (Tanita Innerscan BC545N) is unable to accurately monitor changes in fat and lean mass over a lifestyle intervention lasting 10 weeks. Compared to the reference DXA, the Tanita only assessed 61% and 18% of the respective mean quantitative changes in fat and lean mass. Whilst the within-device effect sizes for change-scores for fat and lean mass were similar between BIA and DXA (small or trivial changes respectively), the between-device comparisons showed poor agreement, with moderately weak correlations for fat and lean tissue (0.511 and 0.362) and large effect size for the differences (0.72-0.79).
A range of other BIA devices have been recently investigated to determine their ability to monitor changes in body composition over a lifestyle intervention, including Omron (Pietiläinen et al., 2013) , InBody (Sillanpaa, Hakkinen, & Hakkinen, 2013) , ImpiMed (Bosaeus et al., 2013; Moon et al., 2013; Thomson et al., 2007) , BodyStat (Verdich et al., 2011) ; RJL systems (Aslam et al., 2009 ). Since comparing BIA devices of different manufacturers is not the focus of this study, although an overview is available (Jaffrin, 2009) , subsequent commentary will be predominantly restricted to the performance of Tanita BIA devices. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Thomson et al., 2007) . Recently the Tanita TBF-300A was considered acceptable for qualitative assessment of body changes in diabetic patients, but not sensitive enough to monitor quantitative changes in an individual (Miyatani et al., 2012) . In 2013 the Tanita BC-418 was used on a sample of Taiwanese overweight/obese patients during a 6mo weight loss intervention and significantly underestimated body fat loss compared to DXA, showing greater error in those with higher body fat (Li et al., 2013) .
To date we are not aware of published work examining a dual-frequency Tanita BIA to assess changes in fat, lean mass, and potentially bone, using apparently healthy male and female individuals and over an intervention aimed at reducing fat and increasing lean mass. The results demonstrate that the BC-545N significantly under-reported the mean losses in body fat (the Tanita only reported 60.5% of the fat loss determined via DXA), and also grossly underreported the mean increase in lean mass (the Tanita reported less than 18% of the lean mass gain determined via DXA). Changes in bone mass determined both by DXA and BIA were, as predicted, trivial and of no practical significance, other than to demonstrate they could be monitored using BIA with some degree of accuracy (i.e., agreement of no change) when compared to the reference DXA.
The efficacy of using BIA to monitor changes in bone mass longitudinally remains an area of potential research, especially for countries without routine access to DXA technology. Although the moderately weak correlations between absolute changes in mass over the intervention for fat and lean tissue show that the BC545N provides some useful qualitative (directional) information about these changes in body composition (70% accuracy of a gain v loss), the BIA is not adequately sensitive to monitor the magnitude (quantitative changes) of body composition variation in these individuals. This is supported by the Bland-Altman plots (Figure 1 The change-score LOA's from Table 2 are also considerably larger than the mean change reported by the BIA or DXA and are in line with the change-score effect sizes in suggesting the absolute changes seen over this short intervention were of small or trivial practical significance. However, statistically these changes were unlikely to have happened via chance alone, and for many individuals losing an average of 0.8kg of fat mass and gaining nearly 0.5kg of lean tissue (as determined via DXA) is likely to have been an important, rewarding, and healthenhancing event. Yet the BC545N would typically not have been able to adequately reflect the magnitude of these changes at the individual level. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The strengths of this study was the examination of whether, compared to a DXA reference, the consumer-oriented BC545N could monitor changes in body composition over a short-term intervention using a respectable number (n=136) of apparently healthy individuals (many of whom were ethnic Chinese, a group that has been understudied via BIA); it also used an intervention that targeted not only fat loss but also lean mass gain. There are several clear limitations.
Both DXA and BIA measurements are sensitive to hydration levels and food intake, and all participants were asked to attend in a state of normal hydration and standard conditions (no prior exercise nor food in the previous 4 hours; void bowels and bladder, same time of day, etc.), but this 4hr period was not a long as a 8-12hr fast used in some highly controlled laboratory studies as we felt this longer fast would have significantly compromised compliance within our "lifestyle study". Thus, some daily variations in hydration/digestion are possible, but likely to have been random and affected both devices simultaneously as the DXA and BIA scans were taken only a few minutes apart for each individual, thus the important change-score would not have been differentially affected. The intervention only lasted a relatively short 10 weeks, however, this still permitted statistically significant changes in both fat and lean mass, although these changes were of low clinical importance. As the participants did not follow a unified/consistent dose of exercise, considerable heterogeneity/variability in the responses (fat and lean mass change) was expected and this possibly inflated the LOA values. DXA is not a sufficiently adequate criterion method, but it is only a common reference (Bilsborough et al., 2014; Miyatani et al., 2012) , and since not all measurements were taken by a single technician, but rather by qualified densitometrists using a standardized protocol, some variations in analysis might occur. Although BIA is predominantly used to estimate body water and fat mass, it is also now regarded as being suitable to assess lean mass (Böhm & Heitmann, 2013; Bosaeus et al., 2013; Janssen, Heymsfield, Baumgartner, & Ross, 2000) , and recently also used to predict bone mass in developing nations (Ekbote, Khadilkar, Chiplonkar, Mughal, & Khadilkar, 2013; Patil et al., 2012) , yet further work remains to further validate its use in predicting bone mass.
Conclusions
Changes in whole body fat following a lifestyle intervention only showed mediocre agreement using the Tanita BC545N BIA device, with 61% of the mean quantitative change determined by DXA being detected and 70% accuracy in the qualitative changes (gain v loss). However, this BIA device showed poor agreement in changes in lean mass, with less than 18% of the mean quantitative changes detected, even though 70% of the qualitative changes (gain v loss) agreed with DXA. Insufficient changes in bone mass occurred to allow any firm conclusions to be made. Overall, the Tanita BC545N BIA significantly underestimated the magnitude of changes in both fat and lean mass compared to DXA, with effect sizes of these changes being greater than 0.7. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w O n l y 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48 
